Thomas E. Starzl, M.D., Ph.D.
This content is PDF only. Please click on the PDF icon to access.
The four major immunosuppressants in clinical use today are azathioprine, cyclophosphamide, prednisone, and antilymphocytic globulin—used in combinations of two or three agents.
After organ transplantation the maximum requirement for treatment with these drugs is usually during the first few post-operative weeks. If this dangerous phase of convalescence can be negotiated, the homograft often appears to be "accepted" in a relative sense so that heavy maintenance immunosuppression is not required. Thereafter, good chronic transplant function may continue in a patient who has retained the ability to deal with inimical environmental antigens, including pathogenic bacteria, and who therefore may now return in
Learn more about subscription options.
Register Now for a free account.
Starzl TE. Transplantation Immunology.. Ann Intern Med. 1972;76:854. doi: 10.7326/0003-4819-76-5-854_3
Download citation file:
Published: Ann Intern Med. 1972;76(5):854.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only